The Consortium team is pleased to share that users now may benefit from a trial access to Thieme Pharmaceutical Substances. The trial will expire on 31 December 2021.
Pharmaceutical Substances is designed to be a complete reference guide to every pharmaceutical compound of significance. It provides a compendium of some 2,500 active pharmaceutical ingredients (API’s), making it an invaluable resource for anybody involved in the design, discovery, development, and evaluation of drugs.
It provides ready access to
- syntheses, patents, and applications for more than 2,700 active pharmaceutical ingredients (APIs)
- including intermediates
- from the six most important markets.
Access is possible for every user with a valid library card of the National Library, University of Luxembourg, LIST or LIH.